137 related articles for article (PubMed ID: 35072591)
1. The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients.
Müller M; Igarashi A; Hashiguchi K; Kappel M; Paolini F; Yoshisue H; Funakubo M; Sharma H; Okano M
J Med Econ; 2022; 25(1):220-229. PubMed ID: 35072591
[TBL] [Abstract][Full Text] [Related]
2. Add-On Omalizumab for Inadequately Controlled Severe Pollinosis Despite Standard-of-Care: A Randomized Study.
Okubo K; Okano M; Sato N; Tamaki Y; Suzuki H; Uddin A; Fogel R
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3130-3140.e2. PubMed ID: 32422373
[TBL] [Abstract][Full Text] [Related]
3. Present state of Japanese cedar pollinosis: the national affliction.
Yamada T; Saito H; Fujieda S
J Allergy Clin Immunol; 2014 Mar; 133(3):632-9.e5. PubMed ID: 24361081
[TBL] [Abstract][Full Text] [Related]
4. Effect of Asian sand dust on Japanese cedar pollinosis.
Ogi K; Takabayashi T; Sakashita M; Susuki D; Yamada T; Manabe Y; Fujieda S
Auris Nasus Larynx; 2014 Dec; 41(6):518-22. PubMed ID: 24928063
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of clinical efficacy and cost-quality of antihistamines in early treatment for Japanese cedar pollinosis].
Kakutani C; Ogino S; Ikeda H; Enomoto T
Arerugi; 2006 May; 55(5):554-65. PubMed ID: 16883093
[TBL] [Abstract][Full Text] [Related]
6. The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status.
Hojo M; Ohta K; Iikura M; Hirashima J; Sugiyama H; Takahashi K
Allergol Int; 2015 Apr; 64(2):150-5. PubMed ID: 25838090
[TBL] [Abstract][Full Text] [Related]
7. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season.
Okubo K; Gotoh M; Shimada K; Ritsu M; Okuda M; Crawford B
Int Arch Allergy Immunol; 2005 Feb; 136(2):148-54. PubMed ID: 15650312
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
Okubo K; Ogino S; Nagakura T; Ishikawa T
Allergol Int; 2006 Dec; 55(4):379-86. PubMed ID: 17130680
[TBL] [Abstract][Full Text] [Related]
9. [Impact of allergic rhinitis on work productivity: a pilot study].
Kakutani C; Ogino S; Ikeda H; Enomoto T
Arerugi; 2005 Jul; 54(7):627-35. PubMed ID: 16229362
[TBL] [Abstract][Full Text] [Related]
10. Measurement of Japanese cedar pollen-specific IgE in nasal secretions.
Sakaida H; Masuda S; Takeuchi K
Allergol Int; 2014 Sep; 63(3):467-73. PubMed ID: 24957114
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Japanese cedar pollinosis among schoolchildren in Japan.
Ozasa K; Dejima K; Takenaka H
Int Arch Allergy Immunol; 2002 Jun; 128(2):165-7. PubMed ID: 12065917
[TBL] [Abstract][Full Text] [Related]
12. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Mitobe Y; Yokomoto Y; Ohashi-Doi K
Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
Fujimura T; Kawamoto S
Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
[TBL] [Abstract][Full Text] [Related]
14. Enhanced production of IgE anti-Japanese cedar pollen specific antibodies by peripheral blood B cells from patients with Japanese cedar pollinosis.
Ohshima N; Hirohata S
Allergol Int; 2008 Jun; 57(2):147-55. PubMed ID: 18349589
[TBL] [Abstract][Full Text] [Related]
15. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
[TBL] [Abstract][Full Text] [Related]
16. Anti-IgE antibody therapy for Japanese cedar pollinosis: omalizumab update.
Okubo K; Nagakura T
Allergol Int; 2008 Sep; 57(3):205-9. PubMed ID: 18724074
[TBL] [Abstract][Full Text] [Related]
17. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Takeda N
J Med Invest; 2022; 69(1.2):97-100. PubMed ID: 35466153
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of sensitization of Japanese cedar pollen in children from infancy to adolescence].
Masuda S; Fujisawa T; Iguchi K; Atsuta J; Noma Y; Nagao M; Nambu M; Suehiro Y; Kamesaki S; Terada A; Mizuno M; Shimizu S; Tohda Y
Arerugi; 2006 Oct; 55(10):1312-20. PubMed ID: 17072111
[TBL] [Abstract][Full Text] [Related]
19. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
Ogino S; Nagakura T; Okubo K; Sato N; Takahashi M; Ishikawa T
Int Arch Allergy Immunol; 2009; 149(3):239-45. PubMed ID: 19218816
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of quality of life (QOL) and efficacy of drug therapy on nasal symptoms and QOL disturbances in the patients with Japanese Cedar Pollinosis during the season of 2003 in Kyushu and Okinawa districts].
Ishikawa T; Soh N
Arerugi; 2004 Nov; 53(11):1131-43. PubMed ID: 15719651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
